Enhancing the Therapeutic Potential of CCL2-Overexpressing Mesenchymal Stem Cells in Acute Stroke

Although intravenous administration of mesenchymal stem cells (MSCs) is effective for experimental stroke, low engraftment and the limited functional capacity of transplanted cells are critical hurdles for clinical applications. C–C motif chemokine ligand 2 (CCL2) is associated with neurological rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sanghun, Kim, Ok Joon, Lee, Kee Ook, Jung, Hyeju, Oh, Seung-Hun, Kim, Nam Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588958/
https://www.ncbi.nlm.nih.gov/pubmed/33096826
http://dx.doi.org/10.3390/ijms21207795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588958/
https://www.ncbi.nlm.nih.gov/pubmed/33096826
http://dx.doi.org/10.3390/ijms21207795

Ejemplares similares